P702: FIRST INTERIM RESULTS OF THE PROSPECTIVE STUDY OF DOSE REDUCTION AND DISCONTINUATION OF TYROSINE KINASE INHIBITORS (READIT-2020) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE

• M. Gurianova,
• O. Shukhov,
• E. Chelysheva,
• A. Petrova,
• A. Bykova,
• I. Nemchenko,
• E. Kuzmina,
• N. Tsyba,
• L. Gavrilova,
• E. Stepanova,
• A. Kohno,
• A. Turkina

Affiliations

M. Gurianova

1 National Research Centre for Hematology, Moscow

O. Shukhov

1 National Research Centre for Hematology, Moscow

E. Chelysheva

1 National Research Centre for Hematology, Moscow

A. Petrova

1 National Research Centre for Hematology, Moscow

A. Bykova

1 National Research Centre for Hematology, Moscow

I. Nemchenko

1 National Research Centre for Hematology, Moscow

E. Kuzmina

1 National Research Centre for Hematology, Moscow

N. Tsyba

1 National Research Centre for Hematology, Moscow

L. Gavrilova

2 Republican Clinical Hospital №4, Saransk, Russia

E. Stepanova

1 National Research Centre for Hematology, Moscow

A. Kohno

1 National Research Centre for Hematology, Moscow

A. Turkina

1 National Research Centre for Hematology, Moscow